That's what Curis has resembled this week, losing ground day after day on low volume/no news selling.. I'm expecting earnings to finally be reported next week, probably monday, which should finally give this stock some kick, followed by (hopefully) CHMP approval on the 22nd, which would send the stock price through-the-roof.
Sorry, I misunderstood your prior posts. I'd been talking about yahoo's calendar, and I thought you were stating that Curis has been reporting a week following yahoo's calendar date, which I noted was initially this prior Monday. Yahoo's calendar date obviously means nothing. Well, hopefully they announce soon, at any rate.
Exactly why do we think CHMP will send this thru the roof when the stock is so weak and Roche is barely selling the product? It might get back to 3.50, may be and CHMP is not guaranteed, we might be repeating this conversation in March. I don't know TA but have you at least seen the chart, do you think there is support here, if so how strong is it? I promised myself this the year I stop behaving like retail investor altogether. Wall St wants to crush u and I, how is else do you explain what has happened to this stock. They were looking at things beyond what we see.
I'm sticking my neck out on this stock at this point in time. I'm not going to be right all the time, but I'm at least 1-for-1 thus far this year on such calls. I doubled the money I'd placed on my Arena put option last month when I predicted correctly that it wouldn't receive CHMP ruling in January, much to the chagrin of all who had bid that stock price up. I feel we will see a strong move up with Curis in the next month or two based on the two catalysts previously mentioned. IMO its highly likely that CHMP rules in the next two months, and it has a good chance to be this month, as its already overdue. As a novel cancer treatment, I also expect it to be approved when this ruling does come. Having a powerful and no doubt influential partner in Roche certainly doesn't hurt its prospects in this regard, either.